The Maximizing Extubation outcomes Through Educational and Organizational Research (METEOR) Trial
通过教育和组织研究 (METEOR) 试验最大限度地提高拔管效果
基本信息
- 批准号:10700877
- 负责人:
- 金额:$ 95.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:Acute respiratory failureAddressAdoptionAdultAreaBreathingCannulasCaringCessation of lifeClinicalClinical ProtocolsClinical TrialsCritical CareDataE-learningEducationEducational InterventionEffectivenessEligibility DeterminationEvidence based practiceFundingGrantHospital MortalityHospitalsInpatientsInterviewIntubationLearningLifeLinkMechanical ventilationMedicalMemoryMorbidity - disease rateNatureNoseOutcomeOxygenPatient riskPatientsPersonsPopulationPreventiveProcessProtocols documentationProviderQualitative EvaluationsRandomizedRandomized, Controlled TrialsRecurrenceResearchRespiratory FailureRespiratory TherapyRiskRoleSeriesSurveysTubeUnited StatesWorkacceptability and feasibilityactive controlclinical centercompare effectivenesscontextual factorsdesigneffectiveness testingeffectiveness/implementation trialface maskhigh riskimplementation barriersimplementation strategyimplementation toolimproved outcomeinnovationinsightintervention refinementmembermortalitynovelpatient orientedpilot testpreventrespiratorytheoriestherapy designventilation
项目摘要
PROJECT SUMMARY
Nearly one million patients require invasive mechanical ventilation for acute respiratory failure in the
United States each year. Most of these patients will recover to the point of extubation, yet even those
who are extubated remain vulnerable to complications and poor outcomes. Multiple high-profile
randomized controlled trials have shown that two preventive post-extubation respiratory therapies—
noninvasive ventilation (NIV) and high-flow nasal cannula oxygen (HFNC)—can prevent recurrent
respiratory failure, reintubation, and death in this population. Despite this evidence, however, these
therapies remain severely underutilized, leading to preventable morbidity and mortality. To address this
implementation gap, we propose to conduct the Maximizing Extubation outcomes Through Educational
and Organizational Research (METEOR) Trial, a cluster-randomized, stepped-wedge, type 2 hybrid
effectiveness-implementation trial of interprofessional education about preventive post-extubation NIV
and HFNC with and without clinical protocols. We designed the METEOR Trial based on extensive
preliminary studies, during which we identified barriers to adoption of preventive post-extubation
respiratory care and pilot tested interprofessional education as an implementation strategy in the ICU.
These studies revealed that a major barrier to implementation is the lack of a shared understanding
about the value of these therapies within the interprofessional ICU team; a theory-based
interprofessional education intervention designed to create a shared understanding and support
“transactive memory” among team members is both feasible and acceptable; and interprofessional
education can be strengthened by linking it with a clinical protocol. During the METEOR Trial, we will
randomize ICUs to one of four implementation strategies: an active control, protocol-directed care,
interprofessional education, or a combination of protocol-directed care and interprofessional education.
In parallel, we will randomize ICUs to one of two clinical strategies, one emphasizing either post-
extubation NIV or HFNC based on patient risk vs. one emphasizing post-extubation HFNC for all
patients. The specific aims of the trial are to (1) test the effectiveness of interprofessional education on
the implementation of preventive, post-extubation therapies, (2) compare the effectiveness of two
preventive, post-extubation therapies (NIV and HFNC) on patient-centered clinical outcomes, and (3)
perform a comprehensive qualitative evaluation of the trial processes and outcomes in order to better
understand mechanism, identify what worked and what didn’t, and set the stage for broader
dissemination of the study findings. Together these aims will provide critical insight into the role of
interprofessional education as an implementation strategy in hospital settings, leading to improved
outcomes for hundreds of thousands of patients with acute respiratory failure.
项目总结
近100万名患者需要有创机械通气治疗急性呼吸衰竭
美国每年都有。这些患者中的大多数都会恢复到拔管的程度,但即使是那些
那些拔管的人仍然容易出现并发症和不良结局。多个高调人物
随机对照试验表明,两种预防性拔管后呼吸疗法-
无创通气(NIV)和高流量鼻插管氧气(HFNC)-可以防止复发
呼吸衰竭,重新插管,以及死亡。然而,尽管有这些证据,这些
治疗仍然严重得不到充分利用,导致可预防的发病率和死亡率。要解决这个问题
实施差距,我们建议通过教育实现最大限度的拔管成果
和组织研究(Meteor)试验,一种集群随机、阶梯楔形、类型2的混合
预防拔管后新生儿静脉感染的跨专业教育实施效果试验
和HFNC,有和没有临床方案。我们设计的流星试验是基于广泛的
初步研究,在此期间,我们确定了采用预防性拔管后的障碍
呼吸护理和试点测试了跨专业教育作为ICU的一项实施战略。
这些研究表明,执行的一个主要障碍是缺乏共同的理解
关于这些疗法在跨专业ICU团队中的价值;基于理论的
旨在建立共同理解和支持的跨专业教育干预
团队成员的“交互记忆”是可行的,也是可以接受的;并且是跨专业的
教育可以通过将其与临床方案联系起来来加强。在流星试验期间,我们将
将ICU随机分为四种实施策略之一:主动控制、协议导向的护理、
跨专业教育,或礼仪指导的护理和跨专业教育的组合。
同时,我们将随机选择两种临床策略之一的ICU,一种强调后-
基于患者风险的拔管NIV或HFNC与强调拔管后HFNC对所有人的比较
病人。试验的具体目的是(1)测试跨专业教育的有效性
预防性、拔管后治疗的实施情况,(2)比较两种方法的效果
预防性、拔管后治疗(NIV和HFNC)对以患者为中心的临床结果的影响;以及(3)
对试验过程和结果进行全面的定性评估,以便更好地
了解机制,确定哪些有效,哪些无效,并为更广泛的发展奠定基础
传播研究结果。这些目标结合在一起,将为我们提供对
将跨专业教育作为医院环境中的一项实施战略,导致改进
数十万急性呼吸衰竭患者的预后。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Timothy D Girard其他文献
The A2F ICU Liberation Bundle in Neurocritical Care
神经重症监护中的 A2F ICU 解放包
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:2
- 作者:
Michael E. Reznik;Alexis Steinberg;Lori Shutter;Timothy D Girard - 通讯作者:
Timothy D Girard
Timothy D Girard的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Timothy D Girard', 18)}}的其他基金
The Maximizing Extubation outcomes Through Educational and Organizational Research (METEOR) Trial
通过教育和组织研究 (METEOR) 试验最大限度地提高拔管效果
- 批准号:
10314540 - 财政年份:2021
- 资助金额:
$ 95.84万 - 项目类别:
SARS-CoV-2 and Precursors of Alzheimer's Disease and Related Dementias: An Ultrahigh Field (7T) MRI Study in a Diverse Multinational Cohort
SARS-CoV-2 和阿尔茨海默病及相关痴呆症的前体:在不同跨国队列中进行的超高场 (7T) MRI 研究
- 批准号:
10440085 - 财政年份:2021
- 资助金额:
$ 95.84万 - 项目类别:
Educational strategies to promote post-extubation non-invasive ventilation in patients with acute respiratory failure
促进急性呼吸衰竭患者拔管后无创通气的教育策略
- 批准号:
9764479 - 财政年份:2018
- 资助金额:
$ 95.84万 - 项目类别:
Mitochondrial Determinants of Cognitive Outcomes in ARDS and Sepsis
ARDS 和脓毒症认知结果的线粒体决定因素
- 批准号:
9883826 - 财政年份:2017
- 资助金额:
$ 95.84万 - 项目类别:
Predictors of Cognitive Impairment in Survivors of Critical Illness
危重疾病幸存者认知障碍的预测因素
- 批准号:
7922527 - 财政年份:2009
- 资助金额:
$ 95.84万 - 项目类别:
Predictors of Cognitive Impairment in Survivors of Critical Illness
危重疾病幸存者认知障碍的预测因素
- 批准号:
8523720 - 财政年份:2009
- 资助金额:
$ 95.84万 - 项目类别:
Predictors of Cognitive Impairment in Survivors of Critical Illness
危重疾病幸存者认知障碍的预测因素
- 批准号:
7707341 - 财政年份:2009
- 资助金额:
$ 95.84万 - 项目类别:
Predictors of Cognitive Impairment in Survivors of Critical Illness
危重疾病幸存者认知障碍的预测因素
- 批准号:
8127802 - 财政年份:2009
- 资助金额:
$ 95.84万 - 项目类别:
Predictors of Cognitive Impairment in Survivors of Critical Illness
危重疾病幸存者认知障碍的预测因素
- 批准号:
8313984 - 财政年份:2009
- 资助金额:
$ 95.84万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 95.84万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 95.84万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 95.84万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 95.84万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 95.84万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 95.84万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 95.84万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 95.84万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 95.84万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 95.84万 - 项目类别:
Research Grant